Mood stabilizer
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
A mood stabilizer is a psychiatric medication used to treat mood disorders characterized by rapid and unstable mood shifts. The most common is bipolar disorder, where mood stabilizers suppress swings between mania and depression, and these drugs are also used in borderline personality disorder. Most mood stabilizers are anticonvulsants, with the important exception of lithium, which is the oldest and best known mood stabilizing drug.
Mood stabilizers include:
- Lithium carbonate —- Lithium is the 'classic' mood stabilizer. The first Food and Drug Administration-approved mood stabilizer, and still popular in treatment. Therapeutic drug monitoring required. Monitor blood lithium levels (therapeutic range: 0.6 or 0.8-1.2 mEq/L) and look for signs and symptoms of toxicity (such as nausea, vomiting, diarrhea, ataxia). See also lithium orotate, another lithium salt.
- Valproic acid (Depakene®), divalproex sodium (Depakote®), and sodium valproate (Depacon®) — Available in extended release form. Can be very irritating to the stomach, especially when taken as valproic acid. Liver function and CBC should be monitored. Therapeutic drug monitoring is required.
- Lamotrigine (Lamictal®) — Particularly effective for bipolar depression. Monitor for signs and symptoms of Stevens-Johnson syndrome, very rare but can be fatal.
- Carbamazepine (Tegretol®) — CBC should be monitored; can lower white blood cell count. Therapeutic drug monitoring is required. Not FDA-approved for bipolar disorder, but widely used for many years.
- Gabapentin (Neurontin®) — Not FDA approved for bipolar disorder. Recent scientific studies suggest it is not an effective treatment, however many psychiatrists continue to use it.
- Oxcarbazepine (Trileptal®) — Not FDA approved for bipolar disorder.
- Topiramate (Topamax®) — Not FDA approved for bipolar disorder.
Sometimes mood stabilizers are used in combination, such as lithium with one of the anticonvulsants.
Many atypical antipsychotics also have mood stabilizing effects and are thus commonly prescribed even when psychotic symptoms are absent. It is also conjectured that Omega-3 fatty acids may have a mood stabilizing effect. However, more research is needed to verify this (a multi-year study of this is now being carried out as of 2001).
Most mood stabilizers are effective at treating mania and mood cycling and shifting, but are not very effective at treating depression (with lamotrigine and lithium carbonate being exceptions). Often, an antidepressant is prescribed in addition to the mood stabilizer during depressive phases. However this brings some risks, as antidepressants can induce mania, psychosis, and other disturbing problems in bipolar patients, particularly when taken alone, but sometimes even when used with a mood stabilizer.
See also
References
- Manic-Depressive Illness by Frederick K. Goodwin and Kay Redfield Jamison.
External links
- Visit Bipolar4all - written by the people who take the medications on a daily basis
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
